|
TTL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.27053964308288E-13 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.4884317656747E-12 |
| Normal-vs-Stage2 |
3.85069999997434E-06 |
| Normal-vs-Stage3 |
2.50111042987555E-12 |
| Normal-vs-Stage4 |
2.633400E-04 |
| Stage1-vs-Stage2 |
9.689800E-01 |
| Stage1-vs-Stage3 |
1.961380E-01 |
| Stage1-vs-Stage4 |
4.270000E-01 |
| Stage2-vs-Stage3 |
3.972800E-01 |
| Stage2-vs-Stage4 |
5.543200E-01 |
| Stage3-vs-Stage4 |
1.480190E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.74915637529693E-12 |
| Normal-vs-AfricanAmerican |
2.393200E-04 |
| Normal-vs-Asian |
4.661000E-01 |
| Caucasian-vs-AfricanAmerican |
4.942600E-01 |
| Caucasian-vs-Asian |
1.616740E-03 |
| AfricanAmerican-vs-Asian |
4.700000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.17061957086662E-12 |
| Normal-vs-Female |
1.69599889687788E-11 |
| Male-vs-Female |
7.372200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.390020E-02 |
| Normal-vs-Age(41-60Yrs) |
1.60650048819377E-10 |
| Normal-vs-Age(61-80Yrs) |
4.24327240011735E-13 |
| Normal-vs-Age(81-100Yrs) |
1.20669999992273E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.937600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.159600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.463820E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.874600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.564200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.355400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.428400E-04 |
| Normal-vs-Grade 2 |
1.0520473381348E-12 |
| Normal-vs-Grade 3 |
5.49438272656744E-12 |
| Normal-vs-Grade 4 |
8.993800E-04 |
| Grade 1-vs-Grade 2 |
9.901600E-01 |
| Grade 1-vs-Grade 3 |
8.740200E-01 |
| Grade 1-vs-Grade 4 |
4.533800E-01 |
| Grade 2-vs-Grade 3 |
6.653400E-01 |
| Grade 2-vs-Grade 4 |
9.573700E-02 |
| Grade 3-vs-Grade 4 |
1.583770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
1.838880E-04 |
| ccA subtype-vs-ccB subtype |
8.14860001696616E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.35400041073797E-10 |
| Normal-vs-N1 |
2.370800E-01 |
| N0-vs-N1 |
2.093000E-01 |
|
|
